| 2026-02-18 | FDA Commissioner Makary and Deputy Prasad Announce End of Two-Trial Drug Approval Standard in NEJM — Most Significant FDA Safety Change Since 1962
7 src Food and Drug Administration · Marty Makary · Vinay Prasad · Donald Trump |
| confirmed |
| 2025-11-06 | Trump Announces Weight Loss Drug Price Deals With Eli Lilly and Novo Nordisk
2 src Donald Trump · Eli Lilly · Novo Nordisk · U.S. Department of Health and Human Services |
| reported |
| 2025-01-15 | Patrizia Cavazzoni's FDA to Pfizer Move Epitomizes Regulatory Capture
3 src Food and Drug Administration · Pfizer · Robert F. Kennedy Jr. |
| confirmed |
| 2024-12-31 | Healthcare Industry Spends Record $744 Million on Federal Lobbying in 2024, Pharmaceutical Sector Leads at $384 Million
4 src PhRMA · American Medical Association · American Hospital Association · Health insurance industry · +1 |
| confirmed |
| 2024-09-20 | FDA Commissioner Califf's Pharmaceutical Industry Revolving Door Scrutinized
3 src Food and Drug Administration · Joe Manchin · Bernie Sanders |
| confirmed |
| 2024-06-27 | Supreme Court Rejects $6B Purdue Pharma Settlement Granting Sackler Family Immunity from Opioid Lawsuits
3 src U.S. Supreme Court · Sackler Family · Purdue Pharma · Department of Justice |
| confirmed |
| 2023-01-01 | Cancer Drug Shortage Crisis Enables Gray Market Profiteering - Carboplatin Price Jumps from $50 to $500 Per Vial
4 src Big Pharma · Food and Drug Administration |
| confirmed |
| 2022-03-15 | FDA Commissioner Confirmed Amid Pharmaceutical Industry Ties Controversy
3 src United States Senate |
| confirmed |
| 2021-10-01 | Former FDA Commissioner Stephen Hahn Joins Moderna Backer Flagship Pioneering
4 src Food and Drug Administration |
| confirmed |
| 2020-05-08 | AbbVie Completes $63 Billion Allergan Acquisition: Pharmaceutical Industry Consolidates Into Oligopoly
3 src AbbVie · Federal Trade Commission |
| confirmed |
| 2019-11-15 | Bristol-Myers Squibb Completes $74 Billion Celgene Acquisition Despite FTC Concerns
3 src Federal Trade Commission |
| confirmed |
| 2018-10-16 | AbbVie Humira Patent Thicket Delays US Biosimilars Until 2023 Despite 2016 Patent Expiration and European Competition
4 src AbbVie · Mylan · Food and Drug Administration |
| confirmed |
| 2018-01-24 | Alex Azar Confirmed as HHS Secretary After Doubling Insulin Prices at Eli Lilly
4 src Alex Azar · Eli Lilly · U.S. Department of Health and Human Services · Ron Wyden · +1 |
| confirmed |
| 2015-11-19 | Johns Hopkins Study Exposes Orphan Drug Act Gaming - Seven of Top 10 Drugs Exploiting Tax Breaks for Rare Diseases
4 src Food and Drug Administration · AbbVie · Johnson & Johnson · AstraZeneca · +2 |
| confirmed |
| 2015-10-31 | Valeant Pharmaceuticals Scandal Exposes Systematic Price Gouging Strategy - 3000% Increase on Syprine, Philidor Fraud Network
4 src Securities and Exchange Commission · Big Pharma |
| confirmed |
| 2014-06-01 | FDA Statistician Joan Buenconsejo Joins AstraZeneca After Overseeing Company Drug Reviews
3 src Food and Drug Administration · AstraZeneca |
| confirmed |
| 2013-06-17 | Supreme Court Allows Antitrust Challenge to Pay-for-Delay Drug Settlements Costing Consumers $3.5 Billion Annually
4 src Supreme Court of the United States · Federal Trade Commission · Big Pharma |
| confirmed |
| 2012-12-05 | ACA Architect Liz Fowler Leaves White House for Johnson & Johnson After Industry-Friendly Healthcare Legislation
4 src Johnson & Johnson · Max Baucus · Barack Obama · U.S. Senate Finance Committee |
| confirmed |
| 2012-09-01 | New England Compounding Center Fungal Meningitis Outbreak Kills 64, Sickens 798 - FDA and State Regulators Ignored Decade of Violations
4 src Food and Drug Administration · Centers for Disease Control and Prevention · U.S. Congress |
| confirmed |
| 2010-12-15 | FDA Arthritis Drug Reviewer Jeffrey Siegel Joins Genentech After Approving Company Tocilizumab
4 src Food and Drug Administration |
| confirmed |
| 2010-04-05 | Purdue Reformulates OxyContin as "Abuse-Deterrent" After 14 Years, Drives Users to Heroin
3 src Purdue Pharma · Food and Drug Administration · Sackler Family |
| confirmed |
| 2009-06-01 | Obama Cuts $80B PhRMA Deal Abandoning Medicare Negotiation Promise
3 src Barack Obama · PhRMA · Billy Tauzin |
| confirmed |
| 2009-01-01 | Energy and Commerce Committee Members Receive $45M From Pharma During ACA Debate
3 src House Energy and Commerce Committee · PhRMA · Pfizer · Merck |
| confirmed |
| 2007-08-27 | Questcor Raises Acthar Gel Price from $1,600 to $23,000 Overnight - Eventually Reaching 97,000% Increase Through Bribery Scheme
4 src Federal Trade Commission · Humana · U.S. Congress · Big Pharma |
| confirmed |
| 2004-09-30 | Merck Withdraws Vioxx After Concealing Heart Attack Risk, FDA Failure Causes Estimated 28,000-55,000 Deaths
3 src Merck · Food and Drug Administration | | confirmed |
| 2003-11-25 | Medicare Part D Passes After Pharmaceutical Industry Writes Price Negotiation Ban
3 src Billy Tauzin · House Energy and Commerce Committee · PhRMA |
| confirmed |
| 2002-01-01 | Insulin Prices Begin Tripling 2002-2013 as Three Manufacturers Control 99% of Market - From $231 to $762 Annually
4 src Eli Lilly · Novo Nordisk · Sanofi · Big Pharma |
| confirmed |
| 2001-01-01 | Purdue Pharma Bonus System Incentivizes Sales Reps to Target Highest Opioid Prescribers
3 src Purdue Pharma · Sackler Family |
| confirmed |
| 1997-11-21 | FDA Modernization Act Accelerates Drug Approvals and Expands Direct-to-Consumer Advertising Under Pharma Pressure
3 src Bill Clinton · PhRMA · Food and Drug Administration | | confirmed |
| 1996-01-01 | Purdue Pharma Launches Aggressive OxyContin Marketing Campaign Based on False Claims
4 src Purdue Pharma · Sackler Family · Richard Sackler |
| confirmed |
| 1995-12-12 | FDA Approval of OxyContin Reveals Systemic Regulatory Capture by Purdue Pharma
3 src Purdue Pharma · Food and Drug Administration · Department of Justice | | confirmed |
| 1992-10-29 | FDA Prescription Drug User Fee Act Creates Financial Dependence on Pharmaceutical Industry
3 src Food and Drug Administration · PhRMA · U.S. Congress |
| confirmed |
| 1984-09-24 | Hatch-Waxman Act Grants Pharma Patent Extensions While Creating Loopholes to Block Generics
3 src Orrin Hatch · Henry Waxman · Ronald Reagan · PhRMA |
| confirmed |
| 1962-10-10 | Thalidomide Scandal Drives Kefauver-Harris Amendment Strengthening FDA Drug Safety Requirements
3 src Estes Kefauver · John F. Kennedy · Food and Drug Administration | | confirmed |